Particle.news

Download on the App Store

Integrated Biosciences’ Optogenetic Platform Advances Toward Aging and Pan-Antiviral Therapies

Now entering extended validation, the platform follows its Cell publication by focusing on age-related, hard-to-drug pathways

Image

Overview

  • The system combines programmable light-responsive domains with AI-driven high-throughput screening to achieve millisecond temporal and micron-scale spatial control over cellular pathways
  • Scientists published their findings in Cell after screening more than 370,000 compounds to selectively activate the integrated stress response
  • Discovered ISR-potentiating molecules upregulate ATF4 and engage GCN2 to sensitize stressed cells to apoptosis without off-target cytotoxicity
  • Lead compounds demonstrated broad-spectrum antiviral efficacy in vitro and significantly reduced disease pathology and viral titers in a mouse ocular herpesvirus model
  • Integrated Biosciences is now extending the platform’s application beyond viral targets into deeper in vivo validation and discovery for age-related and other complex signaling networks